Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

NextCure Inc (NXTC)

  • Technical Exchange News
  • Feb. 07, 2025, 18:43 UTC
  • 27

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Indaptus Therapeutics Inc. (INDP)

  • Technical Exchange News
  • Feb. 07, 2025, 18:43 UTC
  • 30

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Revance Therapeutics (RVNC)

  • Technical Exchange News
  • Feb. 07, 2025, 09:12 UTC
  • 28

Revance Therapeutics (RVNC) was removed from the list of traded instruments on NASDAQ exchange

Comment Full text

Revance Therapeutics (RVNC)

  • Technical Exchange News
  • Feb. 07, 2025, 08:29 UTC
  • 17

NASDAQ symbol attribute type Financial_Status was changed. Previous value: N. New value: Revance Therapeutics, Inc. - Common Stock.

Comment Full text

Revance Therapeutics (RVNC)

  • Technical Exchange News
  • Feb. 07, 2025, 08:29 UTC
  • 24

NASDAQ symbol attribute type Security_Name was changed. Previous value: Revance Therapeutics, Inc. - Common Stock. New value: Revance Therapeutics, Inc. - Common Stock.

Comment Full text

Revance Therapeutics (RVNC)

  • Technical Exchange News
  • Feb. 07, 2025, 08:29 UTC
  • 27

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: Revance Therapeutics, Inc. - Common Stock.

Comment Full text

Cellectar Biosciences Inc. (CLRB)

  • Technical Exchange News
  • Feb. 07, 2025, 02:52 UTC
  • 28

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Revance Therapeutics (RVNC)

  • Technical Exchange News
  • Feb. 07, 2025, 00:56 UTC
  • 24

NASDAQ traded attribute type Security_Name was changed. Previous value: Revance Therapeutics, Inc. - Common Stock. New value: Revance Therapeutics, Inc. - Common Stock.

Comment Full text

Revance Therapeutics (RVNC)

  • Technical Exchange News
  • Feb. 07, 2025, 00:56 UTC
  • 29

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: Revance Therapeutics, Inc. - Common Stock.

Comment Full text

Revance Therapeutics (RVNC)

  • Technical Exchange News
  • Feb. 07, 2025, 00:56 UTC
  • 25

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: Revance Therapeutics, Inc. - Common Stock.

Comment Full text
  • Previous
  • 114
  • 115
  • 116
  • 117
  • 118
  • Next

Search

News categories

  • Technical Exchange News(9382)
  • Event(407)
  • SEC News(153393)
  • FDA Approval(8758)
  • Company Report(721)
  • Business News(104653)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin